An AI-driven Multi-Agent System to Accelerate Biomarker Discovery

29 Jan 2026
AI In Drug Discovery Stage
  • A robust machine learning pipeline designed for biomarker discovery and patient stratification - application in Alzheimer’s disease (AD). 

  • A domain-specific knowledge graph centered on AD biomarkers, generated through literature mining using large language models (LLMs). 

  • An AI multi-agent framework that systematically integrates internal experimental data, omics analyses, clinical trial information, and scientific literature to identify novel biomarkers, facilitating optimized clinical trial design. 

Speakers
Wei Wei
Wei Wei, Associate Principal Scientist - MSD